Nov 10 (Reuters) – Johnson & Johnson said on Tuesday its drug Caplyta eased manic symptoms better than placebo in a second late-stage study of patients with bipolar I disorder, paving the way for a
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
YEMEN'S HOUTHIS SAY THEY ONLY ATTACKED EAST-WEST PIPELINE IN RIYADH NOT MEDINA (The article has…
By Chibuike Oguh NEW YORK, Nov 10 (Reuters) - The dollar strengthened against major currencies…
Nov 10 (Reuters) - Amazon's Ring on Tuesday launched a new robotics business with two…
VIDEO SHOWS: ITALIAN TENNIS PLAYER JANNIK SINNER SPEAKING AT PRESS CONFERENCE IN MILAN RESENDING WITH…
Nov 10 (Reuters) - ABDULLAH AL-OTHAIM MARKETS: * QTRLY NET LOSS 39.26 MILLION RIYALS *…
By Lucia Mutikani WASHINGTON, Nov 10 (Reuters) - US consumer prices increased more than expected…